Disclosures: Tadashi Namisaki: Nothing to Disclose, Yukihisa Fujinaga: Nothing to Disclose, Shinya Sato: Nothing to Disclose, NORIHISA NISHIMURA: Nothing to Disclose, KOSUKE KAJI: Nothing to Disclose, Hitoshi Yoshiji: Nothing to Disclose 2338 ALTERED SERUM BIOMARKERS IN PRIMARY SCLEROSING CHOLANGITIS AFTER PROCTOCOLECTOMY ARE CONSISTENT WITH IMPROVED PROGNOSIS AND REDUCED GUT MICROBIAL IMPACT Sara Kristina Viberg Tjnnfjord 1 Trine Folseraas 1 Hlmfrur Helgadttir 1 Arild Nesbakken 2 Ragnhild Lothe 3 Per Magne Ueland 4 Adrian McCann 4 William Rosenberg 5 Tom Karlsen 1 Mette Vesterhus 1 Johannes Hov 1 Peder Rusten Braadland 1 , 1 Norwegian PSC Research Center, 2 Institute of Cancer Research, 3 Institute for Cancer Research, 4 BEVITAL AS, 5 University College London Medical School Background: Proctocolectomy has recently been associated with improved outcomes in people with primary sclerosing cholangitis (PSC)
Alterations in the gut microbiome implicate key taxa and metabolic pathways across inflammatory arthritis phenotypes
Du, H., Liu, C., Unsalan, O., Altunayar-Unsalan, C., Xiong, S., Manyande, A., & Chen, H
In this article, comparatively transcriptome and metabolome methods are used to fully understand the blue and red-light conditions working on the glutathione metabolism in maize seedling leaf
Glutathione (GSH) injections and NAD+ are administered subcutaneously (beneath or under all layers of the skin)
This is why newborn babies in the UK routinely receive vitamin K supplementation at birth, as they have low stores and limited ability to produce it naturally
